Heartsciences Inc. (HSCS) Stock Price & Analysis

Heartsciences Inc. (HSCS) rose 11.01% to USD 3.73 as of September 8, 2026 at 07:36 UTC, according to Nexqual real-time market data.

HSCS last closed at USD 3.73; the session ranged USD 3.21–3.83 on volume of 182,892 shares. Market capitalization is —, with a 52-week range of USD 1.63–3.83 (NCM). Source: Nexqual, September 8, 2026 at 07:36 UTC.

Key Statistics (as of September 8, 2026 at 07:36 UTC)

Technical Analysis (HSCS)

Nexqual's technical model rates HSCS "BUY" based on 5 bullish and 3 bearish signals across 128 daily candles, as of September 8, 2026 at 07:36 UTC.

From Heartsciences Inc.'s Latest SEC 10-K Filing (filed 2026-07-23)

Key Strengths & Strategy (as disclosed to the SEC)

• Our first commercial product is MyoVista Insights™, a cloud-native, vendor- and device-agnostic ECG management platform designed to modernize ECG workflows and enable scalable deployment of AI-ECG capabilities across healthcare systems.   MyoVista Insights™ is classified as a Medical Device Data System ("MDDS") and is exempt from the FDA 510(k) requirements.
• The device includes conventional ECG functionality, including the Glasgow ECG Interpretation Algorithm, and is designed to incorporate embedded AI-ECG algorithms.   We submitted the MyoVista wavECG device to the FDA for 510(k) premarket clearance in December 2025.
• Also, in these circumstances, the manufacturer may be subject to significant regulatory fines or penalties.   The MyoVista wav ECG device along with its proprietary software and hardware is classified as a Class II medical device by the FDA.
• In addition, the JOBS Act provides that we would cease to be an "emerging growth company" if we have more than $1.235 billion in annual revenue, have more than $700 million in market value of our Common Stock held by non-affiliates (and are not otherwise eligible to be a smaller reporting company), or issue more than $1 billion in principal amount of non-convertible debt over a three-year period.

Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.

Peers & Related Stocks

Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 07:36 UTC. This page is informational and not investment advice.